What You Should Know:
- Mission Bio raises $70 million in Series C funding led by
Novo Growth to accelerate the development of cancer therapies with single-cell multi-omics.
- Mission Bio’s Tapestri Platform, the first single-cell platform capable of detecting DNA and protein changes simultaneously, gives a profound insight into the mutations that drive disease to accelerate the development of novel treatments and save patient lives.
Mission Bio,
Inc., a South San Francisco,
Read More
Biopharma | News, Analysis, Insights - HIT Consultant
Reify Health Raises $30M to Fix The Broken Clinical Trial Ecosystem
What You Should Know:
- Reify Health, a clinical trial software provider
that digitizes and accelerates clinical trials is announcing a $30 million
series B funding round to support the company’s ambitious mission to fix the
broken clinical trial ecosystem.
- The company’s platform, StudyTeam systematically
eliminates redundant work across the clinical trial process while generating
novel insights that speed up trials.
StudyTeam harmonizes biopharma and research
Read More
Moderna Leverages AWS Cloud Platform to Develop New Class of Vaccines and Therapeutics
What You Should Know:
- Moderna, Inc., a biotechnology company pioneering a new
class of messenger RNA (mRNA) medicines, has selected Amazon Web Services
(AWS) as its preferred cloud provider, as well as its standard for
analytics and machine learning workloads.
- By building and scaling its operations on AWS, Moderna
is able to quickly design research experiments and uncover new insights,
automate its laboratory and manufacturing processes to enhance its drug
discovery
Read More
Paige Lands Additional $20M for AI-Native Digital Pathology Ecosystem
What You Should Know:
- Paige secures an additional $15M from Goldman Sachs totaling $20M to close out a total Series B funding round of $70M for its AI-native digital pathology ecosystem.
- The company’s continued product portfolio of innovation in telepathology and digital diagnostics accelerated by further investment.
Paige, an NYC-based leader in computational pathology transforming the diagnosis and treatment of cancer, today announced it received an additional $15M from
Read More
Scripps Research, Repurpose.AI Partner to Develop COVID-19 Therapeutics
What You Should Know:
- Repurpose.AI, has partnered with Scripps Research to
discover drug candidates that may be repurposed to treat COVID-19.
- The partnership will leverage Repurpose.AI's ActivPred
AI Drug Discovery Platform, an unbiased drug, target, and disease agnostic
digital chemistry engine, to discover drug candidates to treat COVID-19.
Scripps Research is
teaming up with Repurpose.AI, an AI
drug discovery company to develop COVID-19 therapeutics. The
Read More
Eliminating the Long, Cumbersome and Costly Diagnosis of Genetic Diseases
The answer to questions about human disease can be found in our genes. The difficulty in the past has been the testing process, a sort of trial and error approach of drilling down into the multitude of variants that can be found within the genes, variants that when analyzed in tandem with detailed clinical histories can actually tell the story and lead to a faster diagnosis.
Human beings carry around 20,000 genes and, of those, approximately 5,000 are somewhat understood, and those genes can
Read More
BrightInsight Raises $40M for Regulated Digital Health Platform for Biopharma & Medtech
What You Should Know:
- BrightInsight, provider of the leading global regulated
digital health platform for biopharma and medtech, today announced a Series B
funding round of $40 million, led by global venture capital and private equity
firm, Insight Partners.
- Already the partner of choice to four global pharmaceutical leaders—AstraZeneca, Roche, CSL Behring, and Novo Nordisk—the Series B financing will enable BrightInsight to speed up hiring, expand its global footprint and add
Read More
MD Anderson, Philips Partner on Personalized Oncology Treatments, Clinical Trial Matching
What You Should Know:
- Philips and MD Anderson collaborate to facilitate
personalized oncology treatments and clinical trial matching based on genomic
markers.
- Philips connects oncologists and pathologists around
the world to MD Anderson’s Precision Oncology Decision Support (PODS) system of
actionable clinical information
Philips and The University of Texas MD Anderson Cancer
Center today announced a collaboration to provide oncologists with
evidence-based therapy and clinical
Read More
Foundation Medicine Acquires Precision Oncology Company Lexent Bio
What You Should Know:
- Foundation Medicine acquires Lexent Bio, a precision oncology company developing novel liquid biopsy platforms.
- The acquisition will accelerate Foundation Medicine’s liquid biopsy R&D and advance cancer care through an expansion of multiomics capabilities.
Foundation Medicine, Inc., announced that it has completed the acquisition
of Lexent Bio, Inc., a precision oncology
company located in California, developing novel multiomics liquid biopsy
platforms
Read More
Intravacc, EpiVax Team Up in Development of COVID-19 Emerging Vaccine
What You Should Know:
- Combines Intravacc's unique OMV delivery platform with
synthetically produced COVID-19 epitopes from EpiVax' immunoinformatics toolbox
- Goal is to generate safe and effective adaptive
immunity against SARS-CoV-2 and related coronaviruses
- Clinical studies anticipated to start in Q4 2020
Intravacc, one
of the world's leading translational research and development vaccine
institutes, with an extensive track record in developing viral and
Read More
